Skip to Main Content

Author Details

Laura J Bierut
1993
420
79
PMIDPaper TitleJournal TitlePublished Year
36178120A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia.Alzheimers Dement2023
38001305Evaluating 17 methods incorporating biological function with GWAS summary statistics to accelerate discovery demonstrates a tradeoff between high sensitivity and high positive predictive value.Commun Biol2023
37935791Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use.2023
37864538Demographic differences in the cascade of care for unhealthy alcohol use: A cross-sectional analysis of data from the 2015-2019 National Survey on Drug Use and Health.2023
37803048COVID-19 pandemic stressors are associated with reported increases in frequency of drunkenness among individuals with a history of alcohol use disorder.Transl Psychiatry2023
37790540Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci.medRxiv2023
37609466Leveraging Implementation Science in the Treatment of Tobacco Use Disorder.2023
37602286Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.2023
37581339The collaborative study on the genetics of alcoholism: Sample and clinical data.Genes Brain Behav2023
37525606Alcohol Consumption and Alcohol Use Disorder: Exposing an Increasingly Shared Genetic Architecture.2023
37436568Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.2023
37232664Predicting Alcohol-Related Memory Problems in Older Adults: A Machine Learning Study with Multi-Domain Features.Behav Sci (Basel)2023
36970994Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims.2023
36898367Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2023
36897142Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People.2023
36792303The Virtuous Cycle of Research.2023
36652753Principal component regression analysis of familial psychiatric histories and suicide risk factors among adults with opioid use disorder.2023
36441691Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder.PLoS ONE2022
35992313Underutilization of guideline-concordant smoking cessation treatments in surgical patients: Lessons from a learning health system.Ann Surg Open2022
35977292Comparison of Performance of Psychiatrists vs Other Outpatient Physicians in the 2020 US Medicare Merit-Based Incentive Payment System.JAMA Health Forum2022
35953715GAWMerge expands GWAS sample size and diversity by combining array-based genotyping and whole-genome sequencing.Commun Biol2022
35931093Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits.Lancet Psychiatry2022
35863765Assessment of formal tobacco treatment and smoking cessation in dual users of cigarettes and e-cigarettes.Thorax2022
35759785Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.Journal of Clinical Psychiatry2022
35704315Association of State Medicaid Expansion Status With Rates of Suicide Among US Adults.JAMA network open2022
35545172Increased Reach and Effectiveness With a Low-Burden Point-of-Care Tobacco Treatment Program in Cancer Clinics.J Natl Compr Canc Netw2022
35544135Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder.JAMA network open2022
35536575Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.JAMA network open2022
35332148Tobacco and nicotine use.Nature Reviews Disease Primers2022
35297970Association Between Workplace Absenteeism and Alcohol Use Disorder From the National Survey on Drug Use and Health, 2015-2019.JAMA network open2022
35170738The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials.Nicotine and Tobacco Research2022
35143583Quantifying rural disparity in healthcare utilization in the United States: Analysis of a large midwestern healthcare system.PLoS One2022
34446379Point of care tobacco treatment sustains during COVID-19, a global pandemic.Cancer Epidemiol2022
36477530Genetic diversity fuels gene discovery for tobacco and alcohol use.Nature2022
33991188Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort.Nicotine and Tobacco Research2021
33653119Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis.American Journal of Psychiatry2021
33652379Racial disparities in intensity of smoke exposure and nicotine intake among low-dependence smokers.Drug Alcohol Depend2021
33625511Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.JAMA network open2021
33617738Understanding barriers to treatment among individuals not engaged in treatment who misuse opioids: A structural equation modeling approach.Substance Abuse2021
32958583Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette Smoking.Cancer Prevention Research2021
32598479Exploring How Social Media Exposure and Interactions Are Associated With ENDS and Tobacco Use in Adolescents From the PATH Study.Nicotine and Tobacco Research2021
34662201Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.Journal of Clinical Oncology2021
32064741Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.Addict Biol2021
34352941Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States.primary care companion for CNS disorders, The2021
34245997An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.2021
36324664High Polygenic Risk Scores Are Associated With Early Age of Onset of Alcohol Use Disorder in Adolescents and Young Adults at Risk.Biol Psychiatry Glob Open Sci2021
34039360In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community.BMC Medical Genomics2021
33993541A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care.Alcoholism: Clinical and Experimental Research2021
31294817Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes.Nicotine Tob Res2020
33295972Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015.JAMA network open2020
  • 1 - 50 of 420

Recommended Authors

Collaborators

Indiana University School of Medicine
Co-authored papers 106
Icahn School of Medicine at Mount Sinai
Co-authored papers 101
Stark Neurosciences Research Institute, Indiana University School of Medicine
Co-authored papers 95
Washington University School of Medicine
Co-authored papers 92
Co-authored papers 91
Co-authored papers 72
Co-authored papers 71
Indiana University School of Medicine
Co-authored papers 67
Co-authored papers 61
Co-authored papers 55
Co-authored papers 42
Co-authored papers 37
Co-authored papers 29
Co-authored papers 28
Co-authored papers 21
Co-authored papers 20
Co-authored papers 20
University of Minnesota
Co-authored papers 19
Co-authored papers 16
Co-authored papers 16
Baylor College of Medicine
Co-authored papers 15
Co-authored papers 15
National Cancer Institute, National Institutes of Health
Co-authored papers 15
Co-authored papers 14
Co-authored papers 14
Nevada Institute of Personalized Medicine, University of Nevada Las Vegas
Co-authored papers 14
University of Oxford
Co-authored papers 14
Co-authored papers 13
Co-authored papers 13
Co-authored papers 13